Mark Fuller

Mark Fuller is an experienced medical professional currently serving as the Medical Strategy Lead at Bayer since January 2015. Mark has held various positions at Bayer, including Senior Manager for Medical Science Liaisons in the Cardiorenal/Diabetes sectors and Medical Advisor roles in Cardiology and Cardiorenal. Prior to joining Bayer, Mark obtained a PhD in Biochemistry and Biomedical Sciences from McMaster University, where the research focused on HDL's protective roles in atherosclerosis. Mark also co-founded the McMaster Graduate Management Consulting Association and contributed as a Team Leader at Strive Volunteer Consulting for Non-Profits. Mark's academic background includes a BMSc in Clinical Biochemistry from Western University and a business administration training from the Wharton School at the University of Pennsylvania.